BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27320893)

  • 1. [Expressions of DAPK3 and c-Myc in endometrial cancer and their relationship with the patients' prognosis].
    Chen C; Guo SQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):863-9. PubMed ID: 27320893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of phosphoglycerate kinase 1 in endometrial carcinoma and its association with patients' outcome].
    Lin L; Jiang QP; Lin D; Chen W; Jiang HP; Liu CH; Xiao YY; Zhu LT; Guo SQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):471-476. PubMed ID: 29735450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas.
    Yokoyama Y; Sagara M; Sato S; Saito Y
    Gynecol Oncol; 1998 Mar; 68(3):280-7. PubMed ID: 9570981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of MACC1/c-Myc Expression in Endometrial Carcinoma with Clinical/Pathological Features or Prognosis.
    Zhang Q; Xu P; Lu Y; Dou H
    Med Sci Monit; 2018 Jul; 24():4738-4744. PubMed ID: 29984790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death-associated protein kinase 3 controls the tumor progression of A549 cells through ERK MAPK/c-Myc signaling.
    Kake S; Usui T; Ohama T; Yamawaki H; Sato K
    Oncol Rep; 2017 Feb; 37(2):1100-1106. PubMed ID: 28075459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear and cytoplasmic c-myc staining in endometrial carcinoma and their relationship to survival.
    Geisler JP; Geisler HE; Manahan KJ; Miller GA; Wiemann MC; Zhou Z; Crabtree W
    Int J Gynecol Cancer; 2004; 14(1):133-7. PubMed ID: 14764041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expressions of APC and c-Myc and its implication on non-small cell lung cancer].
    Wang SF; Liu Q; Zhang SF; Liao DY; Xu H; Zhang WY; Li WM; Liu LX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):822-6. PubMed ID: 21302450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressions and clinical significance of COX-2, VEGF-C, and EFGR in endometrial carcinoma.
    Cai S; Zhang YX; Han K; Ding YQ
    Arch Gynecol Obstet; 2017 Jul; 296(1):93-98. PubMed ID: 28474124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expressions of ZEB2 and C-myc in epithelial ovarian cancer and their clinical significance].
    Wang Q; Jiang H; Deng X; Fang W; Guo S
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1765-9. PubMed ID: 26714913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome.
    Li P; Yin H; Meng F; Liu S; Liu H; Ma R
    Pathol Res Pract; 2018 May; 214(5):727-731. PubMed ID: 29526558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coexpression of MAP2K4 and vimentin proteins in human endometrial carcinoma and its clinicopathological significance].
    Liu CH; Jiang QP; Lin D; Chen W; Xiao YY; Lin L; Deng YR; Jiang HP; Guo SQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 37(2):157-164. PubMed ID: 28219857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Glut1 and c-myc on prognosis in esophageal squamous cell carcinoma of Kazakh and Han patients.
    Zhou YX; Zhou KM; Liu Q; Wang H; Wang W; Shi Y; Ma YQ
    Future Oncol; 2018 Aug; 14(18):1801-1815. PubMed ID: 29629851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between the expression of dual specificity phosphatase-1 and the prognosis of endometrioid adenocarcinoma].
    Gao BR; Yao YY; Chen YH; Li XP; Wang JL; Wei LH
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2493-5. PubMed ID: 24300273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
    Chen H; Wang Y; Xue F
    Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HPIP as a biomarker for metastasis and prognosis prediction in endometrial cancer patients.
    Cheng L; Zhao T; Li S; Wang Y; Fei H; Meng F
    J Clin Lab Anal; 2019 Oct; 33(8):e22959. PubMed ID: 31241209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical significance.
    Hu Y; Yu L; Xia F; Liang F; Cheng C; Huang Y; Xiao L
    Clin Transl Oncol; 2021 Aug; 23(8):1711-1716. PubMed ID: 33635467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of BAF57 expression in patients with endometrial carcinoma.
    Kagami S; Kurita T; Kawagoe T; Toki N; Matsuura Y; Hachisuga T; Matsuyama A; Hashimoto H; Izumi H; Kohno K
    Histol Histopathol; 2012 May; 27(5):593-9. PubMed ID: 22419023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic role of Cul1 and c-Myc: Prognostic and predictive biomarkers in colorectal cancer.
    Wang W; Deng J; Wang Q; Yao Q; Chen W; Tan Y; Ge Z; Zhou J; Zhou Y
    Oncol Rep; 2017 Jul; 38(1):245-252. PubMed ID: 28560438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
    Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Wnt7a is associated with tumor progression and unfavorable prognosis in endometrial cancer.
    Liu Y; Meng F; Xu Y; Yang S; Xiao M; Chen X; Lou G
    Int J Gynecol Cancer; 2013 Feb; 23(2):304-11. PubMed ID: 23321718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.